The transmembrane receptor tyrosine kinase HER2, which stimulates cell division and proliferation, is overexpressed in HER2-positive breast cancer. HER2-positive breast cancers account for 15-20% of all cases. Compared to HER2-negative breast cancers, it is an extremely aggressive form of cancer with rapidly expanding tumors and a significant risk of metastasis and recurrence. In the past, HER2-positive breast cancer had been regarded as having poor prognostic results.
However, considerable progress in precision oncology has changed the approach to treating this condition. Owing to the development of medications that target the HER2 protein, such as monoclonal antibodies, antibody-drug conjugates, and tyrosine kinase inhibitors, the effectiveness of treatment, progression-free survival, and overall survival rates have significantly increased.
Breast cancer treatment has been revolutionized by precision surgery and targeted therapies in combination with chemotherapy, radiation treatment, and personalized care. Proper diagnosis and a multidisciplinary approach are also extremely important factors in successful treatment.
Due to the recent developments in targeted HER2 therapies, previously extremely aggressive cancer has become one of the most treatable types of breast cancer in many cases.
HER2 is an abbreviation that denotes Human Epidermal Growth Factor Receptor 2 - a protein involved in regulating cell growth and repair in the breast.
Characteristics of HER2-positive breast cancer:
HER2-positive breast cancers account for 15-20% of all cases.
HER2-positive breast cancer might occur in:
This type of breast cancer can impact:
Targeted treatments can help destroy cancerous cells without damaging healthy cells.
The causes of HER2-positive breast cancer are still unknown, yet a few contributing factors could increase the probability of this type of cancer developing.
Genetic mutations inherited by people can trigger the development of breast cancer.
Some hormones may influence breast cancer progression.
With aging, there is an increased likelihood of developing breast cancer.
Risk factors could be associated with:
Having a family history of breast cancer increases the general breast cancer risk.
They are similar to those found in other types of breast cancers and may consist of:
Sometimes, symptoms may be absent at an early stage of the disease.
It is crucial for a favorable outcome and successful treatment. Screening assists in diagnosing breast cancer before symptoms occur.
Key screenings are as follows:
Regular breast health checks are required for high-risk women.
Diagnostics and genetic testing are critical since treatment largely depends on them.
Doctors examine the breast and axillary lymph nodes for abnormalities.
The procedure can help identify:
Digital mammography is more precise.
The test can be useful for examining:
MRI provides highly accurate images that can show:
This helps confirm the presence of breast cancer.
The following are determined by analyzing the tissue samples:
Laboratory tests help establish if the cancer is HER2-positive.
Common Tests for HER2 Positivity include:
The tumors may also show:
It describes:
It may involve staging from early stages to later stages, which include:
Staging provides information required for appropriate treatment.
Personalized treatments using various modalities are very common.
Surgeries are common in the early stages of cancer.
This involves removing the tumor but saving the rest of the breast.
It means eliminating the entire breast.
Procedure to examine if cancer has spread to the lymph nodes while making minimal incisions during surgery.
Advancements in reconstructive surgery make it possible to restore breast appearance and provide emotional comfort after a surgical procedure.
Targeted therapy is an innovative solution that makes HER2-positive breast cancer treatment more efficient.
Targeted therapy drugs aim to treat only HER2-positive cancer cells, helping:
Targeted therapy can be prescribed before or after surgery, as well as for advanced cases.
In combination with targeted therapy, chemotherapy improves treatment outcomes.
Types of Chemotherapy:
The chemotherapy used depends on the specific cancer.
Radiation therapy may be a necessity after surgery to avoid cancer recurrence.
Advanced Types of Radiation Therapy Include:
Hormonal therapy can be a part of a personalized treatment plan in case of hormone receptor-positive tumors.
In some aggressive advanced stages of breast cancer, immunotherapy can be applied.
The emergence of new technologies in oncology has greatly transformed the treatment of breast cancer.
The following breast cancer imaging methods improve:
Tests include HER2 Testing and molecular characterization.
Modern surgical methods enhance:
Improved radiation oncology reduces radiation exposure to surrounding healthy tissues, such as the heart and lungs.
Centers offer comprehensive treatment of breast cancer using specialized multidisciplinary techniques.
Planning a personalized treatment plan may involve the collaboration of:
Rehabilitation may include:
Earlier, it used to be that patients with HER2-positive breast cancer faced an extremely poor prognosis.
However, nowadays, due to the development of targeted therapies, there has been a marked improvement in the following areas:
HER2-positive breast cancer patients can respond very well to therapy today.
Long-term follow-up for a patient with HER2 breast cancer is essential to:
Call us at +91-9076972161
Email at care@tenderpalm.com